✦ LIBER ✦

292 POSTER The prognostic influence of Plasminogen Activator Inhibitor-1 in early breast cancer is not related to estimates of angiogenesis

Book ID: 118622872
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 143 KB
Volume: 3
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(05)80590-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cathepsin-D, urokinase plasminogen activ

Cathepsin-D, urokinase plasminogen activator and type-1 plasminogen activator inhibitor in early breast cancer: an immunohistochemical study of prognostic value and relations to tenascin-C and other factors

✍ Jahkola, T; Toivonen, T; Smitten, K von; Virtanen, I; Wasenius, V-M; Blomqvist, 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 284 KB

Expression of plasminogen activator inhi

Expression of plasminogen activator inhibitor-2 in epithelial ovarian cancer: A favorable prognostic factor related to the actions of CSF-1

✍ Setsuko K. Chambers; Christina M. Ivins; Maria L. Carcangiu 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 243 KB 👁 2 views

In ovarian cancer cells, the macrophage colony-stimulating factor-1 (CSF-1) induces the release of plasminogen activator inhibitor-2 (PAI-2), and high levels of PAI-2 as well as of CSF-1 in ovarian cancer ascites are independently correlated with poor outcome. We now study the effect of CSF-1 on PAI